Mexico City, Mexico — The Federal Commission for the Protection against Sanitary Risks (Cofepris) has approved the vaccine Sinopharm for emergency use in Mexico.
The Comité de Moléculas Nuevas (CMN) met August 23 on the use of the Sinopharm vaccine where it was voted. After integrating the opinion of the CMN, the request for authorization for emergency use was presented to the Sanitary Authorization Commission where personnel analyzed the files, certifying that the vaccine complies with the quality, safety and efficacy requirements necessary to be applied.
Sinopharm, which was prequalified by the World Health Organization (WHO) on May 7 of this year, was requested by Laboratorios de Biológicos y Reactivos de México SA de CV (Birmex) for application in people over 18 years of age.
The decisions of the Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris) are recognized by other countries in the region, but not all vaccines approved for emergency use are used in Mexico.